NewEdge Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,406
| Closed | -$20.8K | – | 4076 |
|
|
2024
Q1 | $20.8K | Hold |
1,406
| – | – | ﹤0.01% | 2616 |
|
|
2023
Q4 | $18.9K | Hold |
1,406
| – | – | ﹤0.01% | 2586 |
|
|
2023
Q3 | $17.3K | Hold |
1,406
| – | – | ﹤0.01% | 2415 |
|
|
2023
Q2 | $17.3K | Hold |
1,406
| – | – | ﹤0.01% | 2422 |
|
|
2023
Q1 | $17.3K | Hold |
1,406
| – | – | ﹤0.01% | 2387 |
|
|
2022
Q4 | $16 | Buy |
+1,406
| New | +$16 | ﹤0.01% | 3638 |
|
|
2017
Q3 | – | Sell |
-1,787
| Closed | -$20.1K | – | 1349 |
|
|
2017
Q2 | $20.1K | Buy |
+1,787
| New | +$20.1K | ﹤0.01% | 738 |
|